Inaktiver Wert

SINCLAIR IS PHARMA Aktie Euronext Paris

Aktien

Schlusskurs Euronext Paris Andere Börsenplätze
- ^EUR	-

Sinclair Pharma : Interim Results 2018	27.09.18
European shares bounce as trade deal hopes lift risk appetite	29.08.18
Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)	29.08.18
Huadong Medicine : Sinclair Pharma says Chinese firms given more time to make takeover offer	16.08.18
Huadong Medicine : Britain's Sinclair Pharma gets takeover interest from Chinese firms, shares soar	05.07.18

Manager	Titel	Alter	Seit
Miguel Pardos CEO	Chief Executive Officer	-	01.06.22
Santiago Calavia PRN	Corporate Officer/Principal	-	-
Julie Moreau PRN	Corporate Officer/Principal	-	-

Aufsichtsräte	Titel	Alter	Seit
Cheng Wei Liu CHM	Chairman	50	-
Miguel Pardos CEO	Chief Executive Officer	-	01.06.22
Gen Li BRD	Director/Board Member	-	27.04.23

Sektor

	% 1. Jan.	Kap.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20,81 %	43,34 Mrd.
OTSUKA HOLDINGS CO., LTD.	+20,44 %	21,96 Mrd.
SANDOZ GROUP AG	+13,30 %	14,09 Mrd.
CIPLA LIMITED	+12,97 %	13,64 Mrd.
ZYDUS LIFESCIENCES LIMITED	+39,74 %	11,43 Mrd.
ONO PHARMACEUTICAL CO., LTD.	-8,59 %	6,86 Mrd.
THE MEDICINES COMPANY	-0,05 %	6,79 Mrd.
STADA ARZNEIMITTEL	-8,87 %	5,73 Mrd.
ASPEN PHARMACARE HOLDINGS LIMITED	+9,64 %	5,22 Mrd.